Sinovac Biotech Ltd (SVA) stock
SVANasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.47+0.00 (0.00%)
Close on Nov 17, 2026Market cap $464.94MP/E –Yield 850.08%
Sinovac Biotech operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -$512.18M. The highest annual figure on record is $15.32B in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$512.18M | – |
| FY2024 | Dec 31, 2024 | -$56.89M | -141.0% |
| FY2023 | Dec 31, 2023 | $138.65M | – |
| FY2022 | Dec 31, 2022 | -$798.12M | -105.2% |
| FY2021 | Dec 31, 2021 | $15.32B | +3096.7% |
| FY2020 | Dec 31, 2020 | $479.31M | +1126.7% |
| FY2019 | Dec 31, 2019 | $39.07M | +391.9% |
| FY2018 | Dec 31, 2018 | $7.94M | -86.7% |
| FY2017 | Dec 31, 2017 | $59.76M | – |
| FY2016 | Dec 31, 2016 | -$13.90M | -430.1% |
| FY2015 | Dec 31, 2015 | $4.21M | – |
| FY2014 | Dec 31, 2014 | -$10.13M | -281.6% |
| FY2013 | Dec 31, 2013 | $5.58M | – |
| FY2012 | Dec 31, 2012 | -$16.25M | -216.6% |
| FY2011 | Dec 31, 2011 | $13.94M | – |
| FY2010 | Dec 31, 2010 | -$14.28M | -129.5% |
| FY2009 | Dec 31, 2009 | $48.41M | – |
See a number that looks wrong?